BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 16895684)

  • 41. Hepatorenal syndrome.
    Kramer L; Hörl WH
    Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
    Guevara M; Ginès P; Bandi JC; Gilabert R; Sort P; Jiménez W; Garcia-Pagan JC; Bosch J; Arroyo V; Rodés J
    Hepatology; 1998 Aug; 28(2):416-22. PubMed ID: 9696006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatorenal syndrome: a review.
    Testino G; Ferro C
    Hepatogastroenterology; 2010; 57(102-103):1279-84. PubMed ID: 21410072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hepatorenal syndrome].
    Pŭrvanov P
    Khirurgiia (Sofiia); 2002; 58(2):34-9. PubMed ID: 12515019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatorenal syndrome: new perspectives in pathophysiology and management.
    Kes P
    Acta Med Croatica; 2000; 54(4-5):165-73. PubMed ID: 11379481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
    Gülberg V; Gerbes AL
    Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
    Moreau R; Lebrec D
    Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S; Henriksen JH
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatorenal syndrome: a comprehensive overview for the critical care nurse.
    Fleming JN; Abou Abbass A
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):351-68. PubMed ID: 20691386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M; Cholongitas E; Tibballs J; Burroughs A; Patch D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnostics and therapy of hepatorenal syndrome. Recommendations of of the working group on portal hypertension of the Czech Hepatology Society and the J. E. Purkinje Czech Medical Society].
    Brůha R; Skupiny C; Balihar K; Drastich P; Hůlek P; Lata J; Petrtýl J; Procházka V; Spicák J; Vanásek T; Volfová M; Zdenek P; ;
    Vnitr Lek; 2006 Jun; 52(6):649-50. PubMed ID: 16871772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.
    Møller S; Krag A; Bendtsen F
    Liver Int; 2014 Sep; 34(8):1153-63. PubMed ID: 24673771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapy of hepatorenal syndrome].
    Walter E
    Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatorenal syndrome.
    Bataller R; Ginès P; Arroyo V; Rodés J
    Clin Liver Dis; 2000 May; 4(2):487-507. PubMed ID: 11232202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hepatorenal syndrome].
    Huschak G; Kaisers UX; Laudi S
    Anaesthesist; 2013 Jul; 62(7):571-82. PubMed ID: 23846211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hepatorenal syndrome: focus].
    Gueutin V; Meftah A; Desbuissons G; Debchi L; Langlois AL; Shehwaro N; Izzedine H
    Nephrol Ther; 2013 Dec; 9(7):471-80. PubMed ID: 23850001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ascites and spontaneous bacterial peritonitis: an Asian perspective.
    Lee JM; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1494-503. PubMed ID: 19743995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.